Archives

Sofinnova Partners: €650 Million Raised For Capital XI Fund To Accelerate Early-Stage Healthcare Investments

By Amit Chowdhry ● Nov 17, 2025

Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at €650 million, surpassing its original target and marking one of the firm’s most significant raises to date. The close brings Sofinnova’s total capital raised across its platform to €1.5 billion over the past year, reinforcing its position as one of Europe’s leading life sciences venture capital firms.

Hummink: €15 Million Raised To Advance Micronic Precision Printing For Next-Generation Electronics

By Amit Chowdhry ● Nov 17, 2025

Hummink has raised €15 million in new funding to accelerate the global deployment of its micronic precision printing technology, positioning the Paris-based deep-tech company as a pivotal player in the future of semiconductor and advanced display manufacturing. The round was co-led by KBC Focus Fund, Cap Horn, and Bpifrance, with historic backers including Elaia Partners, Sensinnovat, Beeyond, and the French Tech Seed fund, managed by Bpifrance on behalf of the French government as part of France 2030. The European Innovation Council Fund also participated.

Inocras: Interview With CEO Jehee Suh About The Bioinformatics-Led Whole Genome Insights Company

By Amit Chowdhry ● Nov 17, 2025

Inocras is a bioinformatics-led company redefining precision health through whole-genome data and proprietary analytics. Pulse 2.0 interviewed Inocras CEO Jehee Suh to gain a deeper understanding of the company.

Ghanem: $7.1 Million Raised From Al-Romaih Group To Advance Fractional Ownership Expansion In Saudi Arabia

By Amit Chowdhry ● Nov 17, 2025

Ghanem, a Riyadh-based digital real estate investment platform specializing in fractional ownership solutions, has secured USD 7.1 million in new funding from Al-Romaih Group. The investment marks a significant step forward for one of the Kingdom’s most active emerging real estate technology players, as it works to expand investor access to institutional-grade property opportunities.

Palatine Growth: Michael Ginn Joins As Investment Director

By Amit Chowdhry ● Nov 17, 2025

Palatine Growth Credit has expanded its Manchester-based team with the appointment of Michael Ginn as Investment Director. The hire strengthens the firm’s regional Growth Credit Fund, which launched in 2024 and focuses on providing non-dilutive capital to high-growth entrepreneurial companies across the United Kingdom.

Obello: $8.5 Million Seed Round Raised To Accelerate AI-Driven Creative Production For Leading Global Brands

By Amit Chowdhry ● Nov 16, 2025

Obello, a San Francisco-based AI graphic design platform founded by design leaders behind global brands such as Apple, DoorDash, Nike, Netflix, and Instagram, has raised $8.5 million in new seed funding led by Obvious Ventures. The round included continued participation from Baukunst as well as contributions from AVV and Preview Ventures, bringing the company’s total funding to $9.5 million.

CHAOS: €2 Million Closed To Accelerate AI-Driven Expansion Across Europe’s Real Estate Market

By Amit Chowdhry ● Nov 16, 2025

CHAOS, a Helsinki location intelligence company focused on transforming real estate decision-making through AI, has closed a €2 million funding round to expand its platform across the Nordics and the DACH region. The round included continued backing from its largest investor, Swedish investment company Nidoco, along with participation from Finnvera, the State of Finland’s specialized financing institution.

Gate Bioscience: $65 Million Series B Closed To Advance Oral Molecular Medicines Into Clinical Trials

By Amit Chowdhry ● Nov 16, 2025

Gate Bioscience has closed a $65 million oversubscribed Series B financing round to accelerate the advancement of its emerging class of oral small-molecule medicines, known as molecular gates. The round brings the company’s total capital raised to $135 million, positioning the Brisbane-based biotechnology company to enter the clinic with programs targeting high-value inflammatory and neurological disease proteins.

Scorbit: Over $5 Million Seed Funding Raised As Beta Launch Accelerates Market Momentum

By Amit Chowdhry ● Nov 16, 2025

Scorbit, a connected gaming platform merging physical arcade play with online community and competition, has closed a seed round totaling more than $5 million after achieving rapid traction in its beta phase. The round was led by Detroit Venture Partners, with participation from Grand Ventures, Weiser Family Office, Michigan Rise / Red Cedar, Invest Detroit Ventures, Eberg Capital, Ann Arbor SPARK Capital, Mudita Venture Fund II LLC, Precursor Ventures, Side Door Ventures, Wakestream, Gambit Ventures, and a broad mix of individual and angel investors.

Veritas Capital To Buy MetroStar In Major National Security Technology Deal

By Amit Chowdhry ● Nov 16, 2025

Veritas Capital has agreed to acquire MetroStar Systems, a Reston, Virginia–based provider of digital transformation and AI solutions serving U.S. Defense and National Security agencies. The acquisition, executed through affiliates of The Veritas Capital Vantage Fund, strengthens Veritas’ position within mission-critical government technology while positioning MetroStar for accelerated growth and expanded innovation.

Virometix: $15 Million Financing Raised To Advance Clinical Development Of Synthetic Pneumococcal Vaccine V-212

By Amit Chowdhry ● Nov 16, 2025

Virometix AG has secured a $15 million financing round from its existing shareholders, marking a significant milestone for the Swiss biotechnology company as it accelerates the clinical and developmental progress of its lead synthetic vaccine candidate, V-212. The company, based in Schlieren and focused on next-generation fully synthetic vaccines, confirmed the raise as V-212 continues through its Phase I clinical evaluation.

ClickUp Expands AI Capabilities With Acquisition Of Qatalog

By Amit Chowdhry ● Nov 16, 2025

ClickUp has acquired Qatalog, the AI-powered enterprise work platform backed by $25.4 million in funding, in a move that significantly accelerates ClickUp’s position in converged AI productivity software. The acquisition strengthens ClickUp’s strategy to unify work, data, and automation within a single platform, delivering what the company describes as a true Converged AI Workspace.

Karpowership: $400 Million In Oversubscribed Syndicated Portfolio Financing Closed

By Amit Chowdhry ● Nov 16, 2025

Karpowership has completed a significant financial milestone with the closing of a $400 million syndicated facility for its affiliate Sea World Energy Holdings Limited. The Mauritius Commercial Bank served as the Sole Mandated Lead Arranger and Account Bank for the transaction, which represents the company’s first portfolio financing and a significant advancement in its long-term capital strategy.

BlackRock And ACS Creating €2 Billion Data Center Venture

By Amit Chowdhry ● Nov 16, 2025

ACS Group and Global Infrastructure Partners (part of BlackRock) have announced a major joint venture that will create a global data center development and operations platform anchored by an initial 1.7 gigawatts of capacity. The 50-50 partnership combines ACS’s advanced engineering and construction capabilities with GIP’s global investment expertise to meet the rapidly increasing demand for large-scale, sustainable digital infrastructure.

MacKenzie Scott Donates Record $50 Million To Winston-Salem State University

By Amit Chowdhry ● Nov 16, 2025

Winston-Salem State University has secured the largest single donation in its 133-year history with a new $50 million gift from philanthropist MacKenzie Scott. This commitment, which surpasses her previous $30 million contribution made in 2020, brings Scott’s total support for the university to an unparalleled $80 million. The scale of the investment positions WSSU among the nation’s most significant recent beneficiaries of philanthropic giving to historically Black institutions and public universities.

Legence Announces Acquisition Of Bowers In $475 Million Deal

By Amit Chowdhry ● Nov 16, 2025

Legence announced that it has signed a definitive agreement to acquire The Bowers Group, a leading mechanical contractor based in Beltsville, Maryland. The deal represents a significant expansion of Legence’s mechanical capabilities across the Northern Virginia and Washington, DC metropolitan region while deepening its reach into the data center, technology, healthcare, and life sciences sectors.

Cisco To Buy NeuralFabric To Expand Enterprise AI Capabilities

By Amit Chowdhry ● Nov 16, 2025

Cisco announced its intention to acquire NeuralFabric, a Seattle-based provider of enterprise AI platforms, in a move designed to accelerate the company’s strategy for delivering domain-specific AI models and reinforce its position in the rapidly evolving enterprise AI market. The acquisition is expected to close in the second quarter of Cisco’s fiscal year 2026.

Chubb Unveils New AI Engine To Power Embedded Insurance Growth For Digital Partners

By Amit Chowdhry ● Nov 16, 2025

Chubb announced the launch of a new AI-driven optimization engine within Chubb Studio, its global embedded insurance distribution platform. Revealed at the Singapore Fintech Festival, the new capability is designed to personalize insurance offerings at the point of sale, helping digital partners expand engagement, conversions, and revenue.

PFG Selects United Planners As New Broker-Dealer In Strategic Move

By Amit Chowdhry ● Nov 16, 2025

PFG, a Phoenix-based wealth-management services firm overseeing nearly $5 billion in assets under administration, has selected United Planners Financial Services as its new broker-dealer, marking a significant shift as the firm transitions away from Osaic. The move affects more than 80 financial advisors and over 20 bank and credit union partners, reflecting approximately 90% retention of advisors, assets, and revenue.

71 West Capital Partners Launches As An Independent RIA

By Amit Chowdhry ● Nov 16, 2025

71 West Capital Partners has officially launched as a full-service registered investment advisor following the departure of longtime UBS Financial Services executives Denis Cleary and Greg Devine. The new firm, headquartered in Boston with a second office in Los Angeles, marks a significant move within the wealth management sector as the co-founders leverage independence to expand capabilities for ultra-high-net-worth clients across the United States.

Day One Biopharmaceuticals To Buy Mersana Therapeutics In Deal Valued Up To $285 Million

By Amit Chowdhry ● Nov 16, 2025

Day One Biopharmaceuticals agreed to acquire Mersana Therapeutics. This move will significantly expand its oncology portfolio with the addition of emiltatug ledadotin, also known as Emi-Le. The investigational antibody drug conjugate is being explored as a potential first-in-class monotherapy for adenoid cystic carcinoma type 1, a rare and aggressive cancer with limited therapeutic options and a highly unmet medical need.

Postman Bolsters API Lifecycle Platform With Acquisition Of liblab

By Amit Chowdhry ● Nov 16, 2025

Postman has acquired liblab, a developer platform known for automating Software Development Kit generation, marking a significant expansion of Postman’s capabilities across the full API lifecycle. The acquisition strengthens Postman’s position in the rapidly growing API-first ecosystem and advances its strategy to deliver an integrated platform for building AI-ready and agent-enabled APIs.

PeptiSystems: Major Growth Equity Investment Raised From Rubicon Healthcare Partners

By Amit Chowdhry ● Nov 16, 2025

PeptiSystems has secured a significant growth equity investment from Rubicon Healthcare Partners, marking a pivotal step in the company’s plan to expand its commercial presence and scale its advanced manufacturing technologies for peptide and oligonucleotide therapeutics. The investment positions Rubicon as the largest shareholder in the Uppsala-based life science company. It provides new capital to accelerate both international expansion and the development of next-generation manufacturing solutions for a rapidly growing biopharmaceutical market.

Monomoy: Third Credit Opportunities Fund Closed Above $500 Million Target

By Amit Chowdhry ● Nov 16, 2025

Monomoy Capital Partners has closed its third credit opportunities fund, reaching a total of more than $500 million in commitments, marking a significant milestone for the New York–based private investment firm as it continues to expand its middle-market credit strategy. The raise was completed in just 10 months and represents a growth rate of more than 70% compared to Monomoy Credit Opportunities Fund II, which closed in 2023. The firm achieved this result despite a challenging fundraising climate, drawing strong participation from returning investors, as well as a broad range of new global limited partners.

U.S. Dermatology Partners Expands Footprint With Acquisition Of Helms Dermatology In Arkansas

By Amit Chowdhry ● Nov 16, 2025

U.S. Dermatology Partners has expanded its national presence through the acquisition of Helms Dermatology, marking the organization’s first entry into Arkansas and bringing its total footprint to nine states. The deal reflects the continued growth momentum of the Dallas-based dermatology group, which Castle Connolly recently recognized as the number one dermatology group in the United States.

CHAOS Industries: $510 Million Raised To Accelerate Expansion And Advance Next-Generation Defense Systems

By Amit Chowdhry ● Nov 16, 2025

CHAOS Industries has closed a $510 million funding round led by Valor Equity Partners, marking one of the most significant recent investments in defense technology and valuing the company at $4.5 billion. The Los Angeles-based firm, known for developing Coherent Distributed Networks (CDN) that provide warfighters critical time to respond to threats, has now raised more than $1 billion in just three years. The new funding will support expanded product development and accelerated manufacturing as global drone activity intensifies.

Booster Therapeutics: $5 Million Grant Secured From The Michael J. Fox Foundation

By Amit Chowdhry ● Nov 16, 2025

Booster Therapeutics has received a $5 million research grant from The Michael J. Fox Foundation for Parkinson’s Research. The award, part of the Foundation’s Therapeutics Pipeline Program, will accelerate the development of a new class of small-molecule proteasome activator medicines aimed at restoring the cell’s natural quality control systems and clearing harmful proteins associated with Parkinson’s and other complex diseases.

Beacon Biosignals: $86 Million Series B Raised To Advance AI-Driven Neurodiagnostics And Precision Neuroscience

By Amit Chowdhry ● Nov 16, 2025

Beacon Biosignals has raised an oversubscribed $86 million Series B to accelerate the clinical adoption of AI-powered biomarkers for neurological and psychiatric disease, expand its precision medicine data platform, and scale its neurodiagnostic infrastructure. The financing was backed by Innoviva, Google Ventures (GV), Nexus NeuroTech Ventures, S32, Catalio Capital Management, and Takeda, with continued participation from General Catalyst, Logos Capital, Casdin Capital, and Indicator Ventures. This new capital brings the company’s total funding to over $121 million.

Azumuta: €8 Million Series A Closed To Advance AI-Driven Digital Work Instructions For Global Manufacturers

By Amit Chowdhry ● Nov 16, 2025

Azumuta, a Ghent-based software scale-up focused on digitalizing frontline manufacturing operations, has secured €8 million in Series A funding to accelerate development of its operator-centric platform. The financing round was led by Keen Venture Partners, with participation from Capricorn Partners and returning investors PMV, Angelwise, and Dirk Vermunicht.

4TEEN4 Pharmaceuticals Extends Series C To €55 Million To Advance Clinical Development Of Procizumab In Cardiogenic Shock

By Amit Chowdhry ● Nov 16, 2025

4TEEN4 Pharmaceuticals has expanded its Series C financing round to €55 million, securing participation from both existing and new investors to accelerate the development of its lead monoclonal antibody therapy, procizumab, for patients suffering from cardiogenic shock. The company will use the additional capital to support further its ongoing multicenter Phase 2a PROCARD 2a clinical trial, broaden the study footprint across Europe, and prepare for planned expansion into the United States.